Exploring purinergic and inflammatory pathways in bipolar disorder: evidence for diagnostic utility of UA, IL-6, NACHT, P2X7, ADA, XDH, ADO

Key Points

• Bipolar disorder may involve purinergic and inflammatory pathways, indicating new diagnostic utility.
• Key biomarkers include NACHT, P2X7, ADA, and XDH, highlighting their potential in treatment monitoring.
• Analysis of biomarkers could lead toward biologically informed therapies, enhancing patient care.
• Findings point to the need for further exploration of these pathways in a clinical setting.